James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 2,840 shares at $42.79 ($122K) on 2024-11-29, disclosed to the SEC on 2024-12-02.
Scheduled sale ($122k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.79 | 1,420 | $61K | 50.0% |
| 2 | $42.79 | 1,420 | $61K | 50.0% |
| Total | $42.79 avg | 2,840 | $122K | 100% |
| Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |
| MRNA | SELL | 2024-07-09 | $163K | — | Filing → |